There is a lot to learn from the life story of Jacqueline Colaco, 68, a National Hockey Champion and highly successful banker, who was struck by Rheumatoid Arthritis at age 36. But she bravely fought the disease with surgeries, medications and a positive winning-over-whining approach. Today, she is a beacon of hope and inspiration to fellow sufferers.
She was what every girl aspires to be. A school Head Girl, National Champion of Women’s Hockey, distinction in BCom in college, a highly…
Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Condition
Changed
Sat, 09/06/2014 - 10:22